319 related articles for article (PubMed ID: 25956371)
1. Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors.
Helpman L; Beiner ME; Aviel-Ronen S; Perri T; Hogen L; Jakobson-Setton A; Ben-Baruch G; Korach J
Fertil Steril; 2015 Jul; 104(1):138-44. PubMed ID: 25956371
[TBL] [Abstract][Full Text] [Related]
2. Fertility preservation in women with borderline ovarian tumors - how does it impact disease outcome? A cohort study.
Helpman L; Yaniv A; Beiner ME; Aviel-Ronen S; Perri T; Ben-Baruch G; Hogen Ben-David L; Jakobson-Setton A; Korach J
Acta Obstet Gynecol Scand; 2017 Nov; 96(11):1300-1306. PubMed ID: 28815550
[TBL] [Abstract][Full Text] [Related]
3. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
4. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
[TBL] [Abstract][Full Text] [Related]
5. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
6. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
7. Fertility and recurrence results of conservative surgery for borderline ovarian tumors.
Boran N; Cil AP; Tulunay G; Ozturkoglu E; Koc S; Bulbul D; Kose MF
Gynecol Oncol; 2005 Jun; 97(3):845-51. PubMed ID: 15896834
[TBL] [Abstract][Full Text] [Related]
8. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
9. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
[TBL] [Abstract][Full Text] [Related]
10. Safety and fertility outcomes after the conservative treatment of endometrioid borderline ovarian tumours.
Jia SZ; Zhang JJ; Liang ZY; Yang JJ; Xiang Y; Jia CW; Leng JH
BMC Cancer; 2018 Nov; 18(1):1160. PubMed ID: 30470202
[TBL] [Abstract][Full Text] [Related]
11. Fertility sparing surgery for ovarian tumors in children and young adults.
Abdel-Hady el-S; Abdel-Hady Hemida R; Gamal A; El-Shamey M
Arch Gynecol Obstet; 2012 Feb; 285(2):469-71. PubMed ID: 21701836
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
[TBL] [Abstract][Full Text] [Related]
13. Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary.
Westermann T; Karabeg E; Heitz F; Traut A; Plett H; Moubarak M; Welz J; Heikaus S; Lax S; du Bois A; Harter P
Int J Gynecol Cancer; 2024 Jun; 34(6):898-905. PubMed ID: 38627034
[TBL] [Abstract][Full Text] [Related]
14. Recurrences and fertility after endometrioma ablation in women with and without colorectal endometriosis: a prospective cohort study.
Roman H; Quibel S; Auber M; Muszynski H; Huet E; Marpeau L; Tuech JJ
Hum Reprod; 2015 Mar; 30(3):558-68. PubMed ID: 25574030
[TBL] [Abstract][Full Text] [Related]
15. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
16. The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: A meta-analysis.
Huang Y; Zhang W; Wang Y
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):319-25. PubMed ID: 27343308
[TBL] [Abstract][Full Text] [Related]
17. Ten years experience in the management of borderline ovarian tumors at Tom Baker Cancer Centre.
Anfinan N; Sait K; Ghatage P; Nation J; Chu P
Arch Gynecol Obstet; 2011 Sep; 284(3):731-5. PubMed ID: 20963432
[TBL] [Abstract][Full Text] [Related]
18. Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors.
Song T; Choi CH; Kim HJ; Lee W; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):204-8. PubMed ID: 21306816
[TBL] [Abstract][Full Text] [Related]
19. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
Marcickiewicz J; Brännström M
Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
[TBL] [Abstract][Full Text] [Related]
20. Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual function.
Campos SM; Berlin S; Matulonis UA; Muto MG; Pereira L; Mosquera MM; Horowitz N
J Psychosoc Oncol; 2012; 30(4):387-401. PubMed ID: 22747104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
